Comparative evaluation of analgesic efficacy of buprenorphine transdermal patch and fentanyl transdermal patch in the management of postoperative pain after lower limb surgery

Saifee Sakina Qutubuddin; Sangeeta Bansal Agarwal; Deepshikha Parashar; Vijaya Laxmi Singh; Garima Gupta

doi:10.18203/2319-2003.ijbcp20243031

Authors

Saifee Sakina Qutubuddin Department of Anaesthesia, Index Medical College & Research Centre, Indore, Madhya Pradesh, India
Sangeeta Bansal Agarwal Department of Anaesthesia, Index Medical College & Research Centre, Indore, Madhya Pradesh, India
Deepshikha Parashar Department of Anaesthesia, Index Medical College & Research Centre, Indore, Madhya Pradesh, India
Vijaya Laxmi Singh Department of Anaesthesia, Index Medical College & Research Centre, Indore, Madhya Pradesh, India
Garima Gupta Department of Anaesthesia, Popular Hospital, Varanasi, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20243031

Keywords:

Buprenorphine, Fentanyl, Post-operative pain, Rescue analgesia, Transdermal patch

Abstract

Background: Postoperative pain represents a significant medical issue that needs immediate attention. Despite advancements in pain management, managing postoperative pain remains challenging. Transdermal drug delivery systems (TDDS) offers a straightforward, reliable, non-invasive, and patient-friendly approach for alleviating post-surgical pain. Hence, this study was planned to evaluate the analgesic efficacy of buprenorphine and fentanyl transdermal patch in the management of post-operative pain after lower limb surgery.

Methods: In this prospective, randomised study, 82 adult patients of either sex undergoing elective lower limb surgery were randomly allocated into two groups- Group A (Transdermal Buprenorphine 20 mg patch) and Group B (Transdermal Fentanyl 50 mcg patch). Postoperative pain was assessed by 10-point Visual Analogue Scale (VAS) every 6 hours following surgery on the first day and then daily for next 4 days. All patients were also monitored for total rescue analgesic requirement, drug-related adverse effect and haemodynamic status. Statistical analysis was carried out using student t-test and Chi-square test. A p-value <0.05 was considered significant.

Results: The mean pain intensity scores were found to be significantly different (p<0.0001) between the two groups, with VAS scores consistently lower in Buprenorphine group as compared to Fentanyl group. Also, Buprenorphine group had the lowest demand for rescue analgesic, with 58.5% of patients requiring two administrations and 36.6% needing only one. Patients belonging to Fentanyl group exhibited higher occurrence of nausea (46.3%), vomiting (46.3%) and pruritus (31.7%).

Conclusions: Our study concludes that transdermal patch of buprenorphine demonstrates superior efficacy and safety profile as compared to fentanyl patch for post-operative pain management in lower limb surgeries.

Metrics

Metrics Loading ...

References

Paladini A, Rawal N, Coca Martinez M, Trifa M, Montero A, Pergolizzi J Jr, et al. Advances in the management of acute postsurgical pain: a review. Cureus. 2023;15(8):e42974.

Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97(2):534-540.

Brennan TJ. Pathophysiology of postoperative pain. Pain. 2011;152(3 Suppl):S33-S40.

Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006;367(9522):1618-25.

Brennan F, Carr D B, Cousins M. Pain management: a fundamental human right. Anesth Analg. 2007;105(1):205-21.

Garimella V, Cellini C. Postoperative pain control. Clin Colon Rectal Surg. 2013;26(3):191-6.

Chou R, Gordon DB, De Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of Postoperative Pain: a clinical practice guideline from the American pain society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' committee on regional anesthesia, executive committee, and administrative council. J Pain. 2016;17(2):131-57.

Gupta N, Gupta A. Transdermal opioids for acute postoperative pain: A road less travelled! J Anaesthesiol Clin Pharmacol. 2023;39(1):147-8.

Arshad Z, Prakash R, Gautam S, Kumar S. Comparison between transdermal buprenorphine and transdermal fentanyl for postoperative pain relief after major abdominal surgeries. J Clin Diagn Res. 2015;9(12):UC01-4.

Choudhury K, Dasgupta P, Paul N, Choudhury KB, Roy B, Maity S. A comparative study of transdermal buprenorphine and oral morphine in the treatment of chronic pain of malignant origin. Ind J Palliat Care. 2018;24(4):500-4.

Albaqami MS, Alqarni AA, Alabeesy MS, Alotaibi AN, Alharbi HA, Alshammari MM, et al. Buprenorphine for acute post-surgical pain: A systematic review and meta-analysis. Saudi J Anaesth. 2023;17(1):65-71.

Vadivelu N, Anwar M. Buprenorphine in postoperative pain management. Anesthesiol Clin. 2010;28(4):601-9.

Poliwoda S, Noor N, Jenkins JS, Stark CW, Steib M, Hasoon J, et al. Buprenorphine and its formulations: a comprehensive review. Health Psychol Res. 2022;10(3):37517.

Taylor KP, Singh K, Goyal A. Fentanyl Transdermal. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.

Likar R. Transdermal buprenorphine in the management of persistent pain-safety aspects. TherClin Risk Manag. 2006;2(1):115-25.

Mastrangelo S, Capozza MA, Triarico S, Attinà G, Maurizi P, Romano A, et al. Opioid transdermal delivery system: a useful method for pain management in children. Ann Transl Med. 2021;9(2):185.

Gourlay GK, Kowalski SR, Plummer JL, Cousins MJ, Armstrong PJ. Fentanyl blood concentration analgesic response relationship in the treatment of postoperative pain. Anesthes Analgesia. 1988;67(4):329-37.

Khandelwal H, Negi A, Govil N, Singh A, Parag K, Bhardwaj BB. Comparative evaluation of analgesic efficacy of buprenorphine transdermal patch and fentanyl patch in management of postoperative pain after arthroscopic lower limb surgery: A randomized controlled trial. J Anaesthesiol Clin Pharmacol. 2021;37(2):272-8.

Rallabhandi S, Chakole V, Singam A. Comparison of transdermal fentanyl patch and intravenous fentanyl for postoperative pain relief in patients undergoing major abdominal surgeries under general anaesthesia. Res J Pharm Technol. 2021;14(4):1915-8.

Canneti A, Luzi M, Di Marco P, Cannata F, Pasqualitto F, Spinoglio A, et al. Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients. Minerva Anestesiol. 2013;79(8):871-83.

Machado FC, Neto GC, Paiva LO, Soares TC, Nakamura RK, Nascimento LF, et al. Use of transdermal buprenorphine in acute postoperative pain: a systematic review. Braz J Anesthesiol. 2020;70(4):419-428.

Kapil RP, Cipriano A, Friedman K, Michels G, Shet MS, Colucci SV, et al. Once weekly transdermal buprenorphine application results in sustained and consistent steady state plasma levels. J Pain Symptom Manage. 2015;46(1):65-75.

Kauser D, Singh D. Comparisons of transdermal buprenorphine patch versus transdermal fentanyl patch for postoperative analgesia in lower limb orthopedic surgery. Ind J Public Health Res Dev. 2022;13(3):91-4.

Aguilar B, Penm J, Liu S, Patanwala AE. Efficacy and safety of transdermal buprenorphine for acute postoperative pain: a systematic review and meta-analysis. J Pain. 2023;24(11):1905-14.

Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin Pharmacol Ther. 1994;55(5):569-80.

Griessinger N, Sittl R, Likar R. Transdermal buprenorphine in clinical practice-a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin. 2005;21(8):1147-56.